Ventyx Biosciences, Inc.
Clinical-stage biopharma developing oral therapies for autoimmune, inflammatory & neuro diseases.
VTYX | US
Overview
Corporate Details
- ISIN(s):
- US92332V1070
- LEI:
- Country:
- United States of America
- Address:
- 12790 EL CAMINO REAL, SUITE 200, 92130 SAN DIEGO
- Website:
- https://ventyxbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of innovative oral therapies for autoimmune, inflammatory, and neurodegenerative diseases. Leveraging expertise in medicinal chemistry, structural biology, and immunology, the company discovers and advances differentiated small molecule therapeutics for conditions with high unmet medical need. Its pipeline includes NLRP3 inhibitors VTX2735 (Phase 2 for recurrent pericarditis) and VTX3232 (Phase 2 for neurodegenerative and cardiometabolic diseases). The inflammatory bowel disease portfolio features S1P1R modulator tamuzimod and TYK2 inhibitor VTX958, both of which have completed Phase 2 clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ventyx Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ventyx Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ventyx Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
